Integrated Computational Investigation of Cannabis sativa Phytoconstituents as Putative Multi-Target Inhibitors in Skin Cancer: A Molecular Docking, Dynamics, and ADMET Profiling Study
Pharmaceuticals · 13.02.2026 · 19 (2) · 315
DOI: 10.3390/ph19020315 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 13.02.2026. Verfasst von Lamiae El Bouamri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Analytical and Molecular Chemistry, Faculty of Sciences Ben M'Sick, Hassan II University of Casablanca, Casablanca 20670, Morocco. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United Arab Emirates University, UAEU–UOS, UAEU.
Abstract (Originalsprache)
Background
Skin cancer progression is driven by the dysregulation of key oncogenic signaling pathways, including EGFR, BRAF V600E, and TGF-β, which collectively promote tumor proliferation, invasion, and metastatic progression. Targeting these pathways using multitarget natural modulators represents a promising therapeutic strategy.
Methods
In this study, forty-nine phytoconstituents from Cannabis sativa were evaluated using an integrated computational approach to explore their inhibitory potential against EGFR, BRAF V600E, and the TGF-β receptor. Molecular docking was performed to assess binding affinities and interaction profiles, followed by ADMET analysis to evaluate pharmacokinetic and safety properties. The top-ranked compounds were further investigated using 200 ns molecular dynamics simulations and MM-GBSA binding free energy calculations to assess the stability and strength of protein–ligand interactions.
Results
Several phytoconstituents exhibited strong binding affinities toward the target proteins, formed stable interactions with key active-site residues, and demonstrated favorable pharmacokinetic profiles with acceptable safety characteristics. Molecular dynamics simulations confirmed the structural stability of the selected protein–ligand complexes, while MM-GBSA analysis supported their favorable binding energetics.
Conclusions
These findings suggest that Cannabis sativa phytoconstituents may represent a promising source of multitarget modulators capable of attenuating EGFR, BRAF V600E, and TGF-β driven oncogenic signaling in skin cancer. This study provides a mechanistic framework that supports further in vitro validation and the development of cannabis-derived therapeutic candidates for targeted skin cancer management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Analytical and Molecular Chemistry, Faculty of Sciences Ben M'Sick, Hassan II University of Casablanca, Casablanca 20670, Morocco.
- Department of Chemistry, College of Science, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
- MCNS Laboratory, Faculty of Sciences, Moulay Ismail University, Meknes 50000, Morocco.
ORCID-Profile: Imane Yamari, Abdelouahid Samadi, Samir Chtita
Förderung
- United Arab Emirates University
- UAEU–UOS
- UAEU
Zitieren
APA
Bouamri, L. E., Laaouina, S., Lakrim, I., Nour, H., Yamari, I., Samadi, A., Bouachrine, M., & Chtita, S. (2026). Integrated Computational Investigation of Cannabis sativa Phytoconstituents as Putative Multi-Target Inhibitors in Skin Cancer: A Molecular Docking, Dynamics, and ADMET Profiling Study. Pharmaceuticals, 19(2), 315. https://doi.org/10.3390/ph19020315
Vancouver
Bouamri LE, Laaouina S, Lakrim I, Nour H, Yamari I, Samadi A, et al. Integrated Computational Investigation of Cannabis sativa Phytoconstituents as Putative Multi-Target Inhibitors in Skin Cancer: A Molecular Docking, Dynamics, and ADMET Profiling Study. Pharmaceuticals. 2026;19(2):315. doi:10.3390/ph19020315
BibTeX
@article{Bouamri2026,
author = {Bouamri, Lamiae El and Laaouina, Salma and Lakrim, Ibtissam and Nour, Hassan and Yamari, Imane and Samadi, Abdelouahid and Bouachrine, Mohammed and Chtita, Samir},
title = {Integrated Computational Investigation of Cannabis sativa Phytoconstituents as Putative Multi-Target Inhibitors in Skin Cancer: A Molecular Docking, Dynamics, and ADMET Profiling Study},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {2},
pages = {315},
doi = {10.3390/ph19020315}
}
EUVIMED